Test to Treat: geographic disparities in COVID-19 antiviral access

Cloud technology with futuristic hologram on smartwatch

A recent study evaluated the accessibility of COVID-19 ‘Test to Treat’ sites by age, rurality, race, and ethnicity.

Vendor misconduct associated with widespread use of non-secure electronic health record systems

Previous article

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News